Return on Equity (ROE)
Updated 344h ago
Sector Performance
30th percentileCFG
7.7%
Sector Median
13.8%
Sector Avg
31.4%
Deep Analysis
Return on Equity (ROE) measures how much profit a company generates for each dollar of shareholders' equity.
CFG's current ROE of 7.7% means it earns $0.077 for every dollar of equity, which is below the sector median of 14.1%, placing the company in the 28th percentile among its peers. The trend data is not available—the year-over-year change, quarter-over-quarter change, and trend direction over the last eight quarters are all listed as N/A, with only a single historical value of 7.7% provided. The combination of a below-median ROE and the absence of trend information offers limited insight into whether performance is improving or deteriorating, which adds uncertainty for investors assessing risk. This metric supports the overall NEUTRAL verdict, as the low relative profitability does not signal a clear advantage or disadvantage when weighed against the lack of directional data.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about CFG?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are CFG's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master CFG's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full CFG research report →CFG
7.7%
Sector Median
13.8%
Sector Avg
31.4%
How CFG's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.